Ultragenyx Pharmaceutical Inc.
60 Leveroni Court
Novato
California
94949
United States
Tel: 415-483-8800
Fax: 415-483-8810
Website: http://www.ultragenyx.com/careers/
Email: info@ultragenyx.com
447 articles about Ultragenyx Pharmaceutical Inc.
-
Ultragenyx Pharmaceuticals Releases Positive Interim 40-Week Bone Treatment Data From Ongoing Pediatric Phase II Study Of KRN23 In X-Linked Hypophosphatemia
7/9/2015
-
Ultragenyx Pharmaceuticals Names Daniel G. Welch As Chairman Of The Board
6/25/2015
-
Ultragenyx Pharmaceuticals Appoints Jayson Dallas, M.D., As Chief Commercial Officer And Senior Vice President
6/22/2015
-
Ultragenyx Pharmaceuticals To Present At The JMP Securities Healthcare Conference
6/17/2015
-
Ultragenyx Pharmaceuticals Announces Completion Of Enrollment In Phase III Study Of Recombinant Human Beta-Glucuronidase In Mucopolysaccharidosis Type 7
6/8/2015
-
Ultragenyx Pharmaceuticals Appoints Dennis Huang As Chief Technical Operations Officer And Senior Vice President
6/4/2015
-
Ultragenyx Pharmaceuticals Releases Positive 16-Week Interim Data From Pediatric Phase II Study Of KRN23 In X-Linked Hypophosphatemia
6/2/2015
-
Ultragenyx Pharmaceuticals Announces First Patient Enrolled In Global Phase III Study Of Aceneuramic Acid (Sialic Acid) Extended Release In GNE Myopathy
5/28/2015
-
Ultragenyx Pharmaceuticals To Present At The Jefferies and Co. 2015 Global Healthcare Conference
5/26/2015
-
Ultragenyx Pharmaceuticals Reports First Quarter 2015 Financial Results And Corporate Update
5/11/2015
-
Ultragenyx Pharmaceuticals To Host Conference Call For First Quarter 2015 Financial Results And Corporate Update
5/6/2015
-
Ultragenyx Pharmaceuticals Granted Additional Orphan Drug Designations For Triheptanoin
4/23/2015
-
Ultragenyx Pharmaceuticals Announces Positive Data From Investigator-Sponsored Trial Of Triheptanoin In Glucose Transporter Type-1 Deficiency Syndrome
4/22/2015
-
Ultragenyx Pharmaceuticals Appoints Daniel G. Welch To Board Of Directors
4/13/2015
-
Ultragenyx Pharmaceuticals Reports Fourth Quarter And Full-Year 2014 Financial Results And Corporate Update
3/26/2015
-
Ultragenyx Pharmaceuticals To Host Conference Call For Fourth Quarter And Full-Year 2014 Financial Results And Corporate Update
3/23/2015
-
Ultragenyx Pharmaceuticals Announces Presentation Of Disease Burden Data In Adult Patients With X-Linked Hypophosphatemia
3/9/2015
-
Ultragenyx Pharmaceuticals To Present At The Barclays Global Healthcare Conference
3/4/2015
-
Ultragenyx Pharmaceuticals To Present At The Cowen and Company 35th Annual Health Care Conference In Boston
2/25/2015
-
Ultragenyx Pharmaceuticals Appoints Michael Narachi To Board Of Directors
2/24/2015